智通财经APP讯，威高股份(01066)发布山东威高骨科材料股份有限公司(688161.SH)2024年度业绩快报公告，营业总收入14.52亿元，同比增长13.14%;归属于母公司所有者的净利润2.22亿元，同比增长97.49%;基本每股收益0.55元。
公告称，报告期内，公司积极执行骨科耗材带量采购政策，通过重新规划产品线、优化成本控制、拓展多元化市场渠道及强化与医疗机构合作，全面提升市场份额和客户覆盖率。公司推进销售模式转型，打造聚焦关键术式的协同销售能力，提升临床服务能力，实施大客户策略，优化产品结构，促进协同销售，提高毛利率。同时，新业务线稳步推进，海外产品注册落地，品牌影响力逐步提升。此外，公司加强精细化绩效管理，优化营销架构和库存管理，提高供应链效率，降低销售费用率，实现了本报告期的业绩增长。
报告期内公司营业利润2.72亿元，较上年同期增长107.61%，利润总额2.71亿元，较上年同期增长105.88%，归属于母公司所有者的净利润2.22亿元，较上年同期增长97.49%，归属于母公司所有者的扣除非经常性损益的净利润2.12亿元，较上年同期增长96.29%，主要原因为报告期内骨科耗材带量采购平稳执行，公司积极调整经营策略，全面提升市场份额和客户覆盖率，实现了本报告期的业绩增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.